Organization Profile

You just read:

After License Deal for Letermovir: Head-to-head Phase 2 Trial Initiated by AiCuris to Demonstrate Superiority of its Novel Drug Pritelivir vs. Valacyclovir for Treatment of Genital Herpes

News provided by

AiCurtis GmbH & Co. KG

Nov 27, 2012, 08:00 ET